HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
47 hedge funds and large institutions have $87.2M invested in HOOKIPA Pharma in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 5 closing their positions.
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
54% more capital invested
Capital invested by funds: $56.6M → $87.2M (+$30.6M)
15% more funds holding
Funds holding: 41 → 47 (+6)
0.3% more ownership
Funds ownership: 3.14% → 3.44% (+0.3%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.9M |
| 2 |
BlackRock
New York
|
+$1.24M |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$805K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$781K |
| 5 |
State Street
Boston,
Massachusetts
|
+$728K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$1.92M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.27M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$1.18M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$161K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$104K |
HOOK Hedge Fund Activity: Q2 2020 in Review
47 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2020, worth a combined $87.2M — up 54% from $56.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new HOOK positions and 5 closed out — a net gain of 6 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.9M. The largest seller was Artal Group, cutting an estimated $1.92M.
- 47 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2020, up from 41 in Q1 2020.
- Funds reported $87.2M of HOOKIPA Pharma stock for Q2 2020, up 54% quarter-over-quarter.
- 11 funds opened new HOOKIPA Pharma positions in Q2 2020 and 5 closed out, a net change of +6 holders.
- The largest HOOKIPA Pharma buyer in Q2 2020 was Fidelity Investments, an estimated $4.9M added.
- The largest HOOKIPA Pharma seller in Q2 2020 was Artal Group, an estimated $1.92M sold.
Based on aggregated 13F filings for Q2 2020.